Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy

por Yalcin, Arzu Didem, Genc, Gizem, Gumuslu, Saadet, Yalcin, Arzu Didem
Publicado 2013

An Overview of the Effects of anti-IgE Therapies

por Yalcin, Arzu Didem
Publicado 2014

Advances in Anti-IgE Therapy

por Yalcin, Arzu Didem
Publicado 2015

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients...

por Yalcin, Arzu Didem, Bisgin, Atil
Publicado 2013

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in mediterranean region between 2011 and 2012

por Yalcin, Arzu Didem, Basaran, Saime
Publicado 2013

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor

por Yalcin, Arzu Didem, Suer, Kaya
Publicado 2015

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy

por Yalcin, Arzu Didem, Kose, Sukran, Gorczynski, Reginald M.
Publicado 2012

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment

por Yalcin, Arzu Didem, Bisgin, Atil, Gorczynski, Reginald M
Publicado 2013

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA

por Yalcin, Arzu Didem, Celik, Betul, Kumru, Selahattin, Gumuslu, Saadet
Publicado 2015

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment

por Yalcin, Arzu Didem, Bisgin, Atil, Kargi, Aysegul, Gorczynski, Reginald M.
Publicado 2012

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis

por Yalcin, Arzu Didem, Gumuslu, Saadet, Parlak, Gizem Esra, Bısgın, Atil
Publicado 2012

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment

por Yalcin, Arzu Didem, Bisgin, Atil, Kargi, Aysegul, Gorczynski, Reginald M.
Publicado 2012

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and aller...

por Yalcin, Arzu Didem, Basaran, Saime, Bisgin, Atil, Polat, Hasan H
Publicado 2013

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma

por Yalcin, Arzu Didem, Bisgin, Atil, Cetinkaya, Ramazan, Gorczynski, Reginald M
Publicado 2013

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Steven...

por Yalcin, Arzu Didem, Bisgin, Atil, Soykam, Gokalp, Sezer, Cem, Akman, Ayse
Publicado 2013

481 Differences in Humoral and Cellular Immunity in Young and Old Individuals

por Yalcin, Arzu Didem, Gorczynski, Reginald M., Sarigul, Munevver, Ulker, Mehtap, Terzioglu, Ender
Publicado 2012

305 Incidence of Allergy in Patients With Benign Lesions of the Vocal Cords: Preliminary Report

por Eyigor, Hulya, Osma, Ustun, Yalcin, Arzu Didem, Yilmaz, Mustafa Deniz, Pirtik, Irfan
Publicado 2012

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone

por Uzun, Rusen, Yalcin, Arzu Didem, Celik, Betul, Bulut, Tangul, Yalcin, Ata Nevzat
Publicado 2016

Human(ized) monoclonal antibodies in atopic patients – state of the art

por YALCIN, ARZU DIDEM, ONBASI, KEVSER, UZUN, RUSEN, HERTH, FELIX, SCHNABEL, PHILIPP ALBERT
Publicado 2020

Common variable immunodeficiency syndrome with right aortic arch: a case report

por Yalcin, Arzu Didem, Aydemir, Nese, Turgut, Huseyin, Erbay, Riza Hakan, Yalcin, Ata Nevzat
Publicado 2004